BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6131613)

  • 1. Recovery from schizophrenic psychosis.
    Szymanski HV; Simon JC; Gutterman N
    Am J Psychiatry; 1983 Mar; 140(3):335-8. PubMed ID: 6131613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive symptoms and schizophrenia a psychopharmacological approach.
    Mauri MC; Bravin S; Fabiano L; Vanni S; Boscati L; Invernizzi G
    Encephale; 1995; 21(5):555-8. PubMed ID: 8529564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with hemofiltration/hemodialysis in schizophrenias].
    Ernst K; Börner I; Herbst A; Klinkmann H; Lindenau K; Osten B; Precht K; Schläfke D; Seidel M
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():114-23. PubMed ID: 6130611
    [No Abstract]   [Full Text] [Related]  

  • 4. Gender-specific associations of depression with positive and negative symptoms in acute schizophrenia.
    Müller MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1095-100. PubMed ID: 17493732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive behaviour therapy for schizophrenia: relationship between anxiety symptoms and therapy.
    Naeem F; Kingdon D; Turkington D
    Psychol Psychother; 2006 Jun; 79(Pt 2):153-64. PubMed ID: 16774715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute-phase and 1-year follow-up results of a randomized controlled trial of CBT versus Befriending for first-episode psychosis: the ACE project.
    Jackson HJ; McGorry PD; Killackey E; Bendall S; Allott K; Dudgeon P; Gleeson J; Johnson T; Harrigan S
    Psychol Med; 2008 May; 38(5):725-35. PubMed ID: 18005494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive symptoms in acute schizophrenic hospitalized patients.
    Lerner Y; Moscovich D
    J Clin Psychiatry; 1985 Nov; 46(11):483-4. PubMed ID: 4055708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic effect of milieu in the acute treatment of schizophrenia.
    Cohen S; Khan A
    Gen Hosp Psychiatry; 1990 Jul; 12(4):248-51. PubMed ID: 2376324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
    Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
    Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopathometric examinations on patients with schizophrenia and related psychoses (author's transl)].
    Möller HJ; von Zerssen D; Werner-Eilert K; Wüschner-Stockheim M
    Arch Psychiatr Nervenkr (1970); 1981; 230(4):275-92. PubMed ID: 6119064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-yield cognitive behavioral techniques for psychosis delivered by case managers to their clients with persistent psychotic symptoms: an exploratory trial.
    Turkington D; Munetz M; Pelton J; Montesano V; Sivec H; Nausheen B; Kingdon D
    J Nerv Ment Dis; 2014 Jan; 202(1):30-4. PubMed ID: 24375209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodromal symptoms and prevention of relapse in schizophrenia.
    Herz M
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):22-5. PubMed ID: 2865253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase-specific psychosocial interventions for first-episode schizophrenia.
    Miller R; Mason SE
    Bull Menninger Clin; 1999; 63(4):499-519. PubMed ID: 10589141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methadone plus neuroleptics on treatment-resistant chronic paranoid schizophrenia.
    Brizer DA; Hartman N; Sweeney J; Millman RB
    Am J Psychiatry; 1985 Sep; 142(9):1106-7. PubMed ID: 2862800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment.
    Peralta V; Cuesta MJ; Martinez-Larrea A; Serrano JF
    Am J Psychiatry; 2000 Sep; 157(9):1461-6. PubMed ID: 10964863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of clinical status of schizophrenic patients by the WAIS comprehension subtest.
    Bigelow LB; Donnelly EP; Torrey EF; Lee CA
    J Clin Psychiatry; 1979 Jun; 40(6):258-61. PubMed ID: 36371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients.
    Yasui-Furukori N; Saito M; Nakagami T; Furukori H; Suzuki A; Kondo T; Kaneko S
    J Psychopharmacol; 2010 Jul; 24(7):987-94. PubMed ID: 19477882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the nature of relapse and subsequent inpatient course between medication-compliant and noncompliant schizophrenic patients.
    McEvoy JP; Howe AC; Hogarty GE
    J Nerv Ment Dis; 1984 Jul; 172(7):412-6. PubMed ID: 6144721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of antipsychotic medication on pain perception in schizophrenia.
    Jochum T; Letzsch A; Greiner W; Wagner G; Sauer H; Bär KJ
    Psychiatry Res; 2006 Jun; 142(2-3):151-6. PubMed ID: 16631931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.